India Britain Canada hospital covid-19 patient Analysis India Britain Canada

Analysis spotlights shortage of a COVID-19 drug in Canada

Reading now: 183
www.cidrap.umn.edu

Tocilizumab, like other potential COVID-19 drug treatments, is in spot shortages around the world.In India, it's being allocated to states by the government.

The UK National Health Service allows patients to receive only one dose. And in Canada, whose use of the drug was the spotlight of a CMAJ analysis yesterday, it's considered to be in tier 3 shortage, a status reserved for potential COVID-19 drugs that allows them to be withheld owing to scarcity.Canada's shortage could cause supply and demand issues, according to the researchers.

They estimate that, if the drug is proven to reduce in-hospital mortality, 42.9% of hospitalized COVID patients in Canada and 40.9% of hospitalized COVID patients in the United States could benefit from

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA